Log in to save to my catalogue

Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer's disease in mice

Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer's disease in mice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10789813

Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer's disease in mice

About this item

Full title

Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer's disease in mice

Publisher

England: Nature Publishing Group

Journal title

Neuropsychopharmacology (New York, N.Y.), 2024-02, Vol.49 (3), p.620-630

Language

English

Formats

Publication information

Publisher

England: Nature Publishing Group

More information

Scope and Contents

Contents

Alzheimer's disease (AD) is a progressive neurodegenerative disease with cognitive dysfunction as its major clinical symptom. However, there is no disease-modifying small molecular medicine to effectively slow down progression of the disease. Here, we show an optimized asparagine endopeptidase (AEP, also known as δ-secretase) inhibitor, #11 A, that...

Alternative Titles

Full title

Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer's disease in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10789813

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10789813

Other Identifiers

ISSN

0893-133X

E-ISSN

1740-634X

DOI

10.1038/s41386-023-01774-2

How to access this item